======= MOCS1 ======= == Gene Information == * **Official Symbol**: MOCS1 * **Official Name**: molybdenum cofactor synthesis 1 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=4337|4337]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q9NZB8|Q9NZB8]] * **Interactions**: [[https://thebiogrid.org/search.php?search=MOCS1&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20MOCS1|Open PubMed]] * **OMIM**: [[https://omim.org/entry/603707|Open OMIM]] == Function Summary == * **Entrez Summary**: Molybdenum cofactor biosynthesis is a conserved pathway leading to the biological activation of molybdenum. The protein encoded by this gene is involved in this pathway. This gene was originally thought to produce a bicistronic mRNA with the potential to produce two proteins (MOCS1A and MOCS1B) from adjacent open reading frames. However, only the first open reading frame (MOCS1A) has been found to encode a protein from the putative bicistronic mRNA, whereas additional splice variants are likely to produce a fusion between the two open reading frames. This gene is defective in patients with molybdenum cofactor deficiency, type A. A related pseudogene has been identified on chromosome 16. [provided by RefSeq, Nov 2017]. * **UniProt Summary**: N/A |Mob synth C| |Radical SAM| |cyclic pyranopterin monophosphate synthase activity| |GTP 3,8-cyclase activity| |molybdopterin synthase complex| |Mo-molybdopterin cofactor biosynthetic process| |Mo-molybdopterin cofactor metabolic process| |molybdopterin cofactor biosynthetic process| |prosthetic group metabolic process| |molybdopterin cofactor metabolic process| |4 iron, 4 sulfur cluster binding| |coenzyme biosynthetic process| |cofactor biosynthetic process| |coenzyme metabolic process| |GTP binding| |cofactor metabolic process| |organophosphate biosynthetic process| |organophosphate metabolic process| |heterocycle biosynthetic process| |organic cyclic compound biosynthetic process| |organonitrogen compound biosynthetic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp218|A-395 10μM R05 exp218]]|-1.8| ^Gene^Correlation^ |[[:human genes:h:hgc6.3|HGC6.3]]|0.445| Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 9774 * **Expression level (log2 read counts)**: -5.01 {{:chemogenomics:nalm6 dist.png?nolink |}}